PLX
PLX
AMEX · Biotechnology

Protalix Biotherapeutics Inc

$2.14
+0.03 (+1.42%)
As of Mar 29, 10:33 PM ET ·
Financial Highlights (FY 2026)
Revenue
44.97M
Net Income
2.47M
Gross Margin
54.5%
Profit Margin
5.5%
Rev Growth
+11.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 54.5% 54.5% 49.5% 49.5%
Operating Margin 7.3% 6.6% 5.5% 5.3%
Profit Margin 5.5% 5.2% 4.3% 3.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 44.97M 40.27M 361.03M 312.42M
Gross Profit 24.49M 21.93M 178.56M 154.52M
Operating Income 3.30M 2.66M 20.00M 16.49M
Net Income 2.47M 1.99M 15.50M 9.93M
Gross Margin 54.5% 54.5% 49.5% 49.5%
Operating Margin 7.3% 6.6% 5.5% 5.3%
Profit Margin 5.5% 5.2% 4.3% 3.2%
Rev Growth +11.7% +11.7% +17.6% +23.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 59.24M 69.52M
Total Equity 91.15M 87.27M
D/E Ratio 0.65 0.80
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 4.40M 3.74M 29.24M 21.92M
Free Cash Flow 6.36M 8.25M